Neoadjuvant therapy
Molecular profiles of genomically High Risk ER+ HER2- breast cancer tumors classified as functionally Basal or Luminal B by the BluePrint
PUBLICATION: ASCO 2021 Authors Joyce O’Shaughnessy1, Virginia G. Read More
Neoadjuvant therapy
PUBLICATION: ASCO 2021 Authors Joyce O’Shaughnessy1, Virginia G. Read More
Publication: St. Gallen Authors: E. Göker, M.P. Hendriks, M. van Read More
Publication: Miami Breast Authors Pat Whitworth, James Read More
PUBLICATION: SABCS 2020 AUTHORS: Peter W. Blumencranz, Mehran Habibi, Read More
PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Pellicane, Jr., Read More
PUBLICATION: SABCS 2020 AUTHORS: Pat Whitworth, James V Read More
I-SPY2, JAMA Oncology, 2020 Authors: Yee et al.
Read MorePUBLICATION: ASCO 20 AUTHORS: Hatem Soliman, Sangeetha Prabhakaran, Marilin Rosa, Read More
AUTHORS: Raquel Nunes, Femke de Snoo, Lisette Stork-Sloots, Tina Treece, Read More
NPJ Breast Cancer, April 2019 Author: Groenendijk et al.
Read More